View Single Post
Old 08-06-2015, 04:16 AM   #1
News
Senior Member
 
News's Avatar
 
Join Date: Oct 2007
Posts: 18,951
Genetic test may help identify better treatment option for HER2-positive breast cance

A genetic test for PIK3CA mutations may help to identify patients with HER2-positive breast cancer who are less likely to benefit from combination anti-HER2 therapy, according to a study published in The Oncologist on August 5, 2015.

More...
News is offline   Reply With Quote